How Is The Market Feeling About Virax Biolabs Group?
Portfolio Pulse from Benzinga Insights
Virax Biolabs Group (NYSE:VRAX) has seen a significant decrease in its short percent of float, dropping by 54.22%. Currently, 1.03% of its shares are sold short, which is below the peer group average of 4.30%. This decrease in short interest may indicate a more bullish sentiment towards the stock.
August 20, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Virax Biolabs Group's short interest has decreased by 54.22%, now at 1.03% of float, indicating a potential shift towards bullish sentiment. This is lower than the peer average of 4.30%.
The significant decrease in short interest suggests that investors are less bearish on VRAX, which could lead to a positive short-term price movement. The short interest is also below the peer average, further supporting a potential bullish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100